Bioresponsive Nucleic Acid Base Pair-Inspired Nanogels for Codelivery of Chemo-/Protein Drugs in Targeted Cancer Therapy
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c01632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Yan Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Jilin Institute of Chemical Technology, Jilin City 132022, Jilin Province P. R. China. Hauptthemen laut MEDLINE: Deoxycytidine, Cytochromes c, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Research Foundation of Korea, National Natural Science Foundation of China, Scientific Research Project of Education Department of Jilin Province.
Abstract (Originalsprache)
Codelivery of chemo- and protein drugs enhances efficacy but faces challenges from physicochemical differences and inefficient release. We fabricated dual-responsive and tumor-targeting nucleic acid base-inspired nanogels (DTNANGs) for the in vivo codelivery of gemcitabine (Gem) and cytochrome C (CC). The nanogels were engineered through pH-sensitive base-pairing cross-linking between guanine- and cytosine-modified hyaluronic acid derivatives. DTNANGs achieved high drug-loading efficiency (96.3% for Gem, 94.5% for CC). In vitro and in vivo experiments confirmed that DTNANGs demonstrated superior CD44-mediated tumor-targeting capacity, enhanced tumor accumulation, improved cellular uptake, and fast endolysosomal escape. Additionally, CC-loaded DTNANGs increased cell apoptosis by 75.5% in A549 cells, outperforming monotherapy. Moreover, in vivo evaluations in A549 tumor-bearing mice revealed that they significantly inhibited tumor growth (70% inhibitory rate) compared to other control groups, while exhibiting negligible systemic toxicity. Our study lays the groundwork for controlled, effective codelivery of chemo- and protein drugs, enabling precision cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Materials Science and Engineering, Jilin Institute of Chemical Technology, Jilin City 132022, Jilin Province P. R. China.
- Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine and Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute, Seoul 06351, Republic of Korea.
ORCID-Profile: Hong Yu Yang
Förderung
- National Research Foundation of Korea
- National Natural Science Foundation of China
- Scientific Research Project of Education Department of Jilin Province
Zitieren
APA
Fu, Y., Jiang, W., Jang, M. S., Hui, H., Liu, C., Lee, J. H., & Yang, H. Y. (2025). Bioresponsive Nucleic Acid Base Pair-Inspired Nanogels for Codelivery of Chemo-/Protein Drugs in Targeted Cancer Therapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01632
Vancouver
Fu Y, Jiang W, Jang MS, Hui H, Liu C, Lee JH, et al. Bioresponsive Nucleic Acid Base Pair-Inspired Nanogels for Codelivery of Chemo-/Protein Drugs in Targeted Cancer Therapy. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c01632
BibTeX
@article{Fu2025,
author = {Fu, Yan and Jiang, Wei and Jang, Moon-Sun and Hui, Hao and Liu, Changling and Lee, Jung Hee and Yang, Hong Yu},
title = {Bioresponsive Nucleic Acid Base Pair-Inspired Nanogels for Codelivery of Chemo-/Protein Drugs in Targeted Cancer Therapy},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c01632}
}
EUVIMED